Business Context and Reporting Period
Company: Collegium Pharmaceutical, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 10, 2016
Reporting Period: Quarterly period ended September 30, 2016
This filing serves as a notification that the company issued a press release announcing its financial results for the quarter ended September 30, 2016. The full text of the press release is attached as Exhibit 99.1.
Key Financial Metrics
The provided filing text does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the attached press release (Exhibit 99.1), which is not included in the input text.
Material Changes
The filing text does not provide specific details on material changes versus the prior comparable period. It only references the announcement of results for the quarter ended September 30, 2016.
Guidance, Outlook, and Risks
The filing text does not include management commentary, guidance, outlook, risks, contingencies, or unusual items. These details are referenced as being part of the attached press release (Exhibit 99.1).
Investor Verification Checklist
- Review the attached press release (Exhibit 99.1) for specific revenue, net loss, and cash position figures for the quarter ended September 30, 2016.
- Verify year-over-year and quarter-over-quarter performance metrics not detailed in this summary.
- Check for any updates on clinical trial progress or regulatory milestones mentioned in the full press release.
- Confirm the company's cash runway and liquidity status as disclosed in the full financial results.